Concepedia

Author

Line Conradsen Hiort

Novo Nordisk (Denmark)

Also Known As

L. C. Hiort, L. Conradsen Hiort, L.-C. Hiort, Line C Hiort, Line Conradsen Hiort

11

Publications

297

Citations

8

H-Index

11

Concepts

All Affiliations

Novo Nordisk (Denmark)Marmara UniversityUniversity of CopenhagenNorfolk and Norwich University HospitalGlostrup Hospital
LC

About

Line Conradsen Hiort is an author at Novo Nordisk (Denmark) specializing in diabetes, medicine, and pediatric endocrinology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

111

2

Diabetes

2

2

111

3

Health Sciences

1

1

20

4

Nutrition

1

1

20

5

Body Composition

1

1

20

Line Conradsen Hiort

×

7

Publications

260

Citations

7

H-Index

YearCitations

Treatment intensification with stepwise addition of prandial insulin aspart boluses compared with full basal-bolus therapy (FullSTEP Study): a randomised, treat-to-target clinical trial

Helena W. Rodbard, Virginia Visco, Henning Andersen,

The Lancet Diabetes & Endocrinology

2013

91

Self-rated general health among 40-year-old Danes and its association with all-cause mortality at 10-, 20-, and 29 years' follow-up

Anni Brit Sternhagen Nielsen, Volkert Siersma, Line Conradsen Hiort,

Scandinavian Journal of Public Health

2008

56

Insulin analogues in children with Type 1 diabetes: a 52‐week randomized clinical trial

Nandu Thalange, Abdullah Bereket, Julie Rask Larsen,

Diabetic Medicine

2012

39

The impact of changes in self-rated general health on 28-year mortality among middle-aged Danes

Anni Brit Sternhagen Nielsen, Volkert Siersma, Svend Kreiner,

Scandinavian Journal of Primary Health Care

2009

25

Treatment with insulin detemir or NPH insulin in children aged 2-5 yr with type 1 diabetes mellitus

Nandu Thalange, Abdullah Bereket, J. B. Larsen,

Pediatric Diabetes

2011

20

Weight change upon once‐daily initiation of insulin detemir with or without dietary intervention in overweight or obese insulin‐naïve individuals with type 2 diabetes: results from the <scp>DIET</scp> trial

Kevin D. Niswender, Milivoj Piletič, Henning Andersen,

Diabetes Obesity and Metabolism

2013

15

The study of once- and twice-daily biphasic insulin aspart 30 (BIAsp 30) with sitagliptin, and twice-daily BIAsp 30 without sitagliptin, in patients with type 2 diabetes uncontrolled on sitagliptin and metformin—The Sit2Mix trial

Sultan Linjawi, Radhakrishna Sothiratnam, Henning Andersen,

Primary care diabetes

2014

14

Page 1